Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 110 | 2024 | 2061 | 8.770 |
Why?
|
Brain Concussion | 80 | 2024 | 1432 | 8.310 |
Why?
|
Football | 38 | 2024 | 504 | 6.360 |
Why?
|
Recovery of Function | 52 | 2024 | 2965 | 4.780 |
Why?
|
Spinal Cord Injuries | 37 | 2024 | 928 | 4.530 |
Why?
|
Athletic Injuries | 38 | 2024 | 1244 | 3.880 |
Why?
|
Rehabilitation Centers | 27 | 2024 | 245 | 2.750 |
Why?
|
Inpatients | 25 | 2024 | 2564 | 2.310 |
Why?
|
Post-Concussion Syndrome | 11 | 2024 | 257 | 2.060 |
Why?
|
Athletes | 37 | 2024 | 1162 | 1.920 |
Why?
|
Glasgow Coma Scale | 27 | 2021 | 574 | 1.820 |
Why?
|
Sports | 7 | 2023 | 699 | 1.670 |
Why?
|
Amantadine | 7 | 2024 | 58 | 1.500 |
Why?
|
Disability Evaluation | 26 | 2022 | 1821 | 1.500 |
Why?
|
Burns | 19 | 2022 | 1904 | 1.490 |
Why?
|
Cytidine Diphosphate Choline | 6 | 2019 | 29 | 1.410 |
Why?
|
Muscle Spasticity | 7 | 2010 | 159 | 1.380 |
Why?
|
Soccer | 7 | 2023 | 142 | 1.350 |
Why?
|
Dopamine Agents | 7 | 2024 | 186 | 1.270 |
Why?
|
Suicidal Ideation | 6 | 2022 | 1465 | 1.250 |
Why?
|
Sports Medicine | 3 | 2021 | 239 | 1.230 |
Why?
|
Cognition | 31 | 2024 | 7045 | 1.170 |
Why?
|
Trauma Severity Indices | 8 | 2021 | 479 | 1.140 |
Why?
|
Stress Disorders, Post-Traumatic | 15 | 2023 | 4627 | 1.130 |
Why?
|
Cognition Disorders | 14 | 2020 | 3966 | 1.110 |
Why?
|
Rehabilitation | 7 | 2023 | 126 | 1.100 |
Why?
|
Epilepsy, Post-Traumatic | 5 | 2021 | 40 | 1.090 |
Why?
|
Physicians, Women | 5 | 2019 | 512 | 1.070 |
Why?
|
Humans | 376 | 2024 | 765823 | 1.070 |
Why?
|
Suicide | 4 | 2023 | 1606 | 1.050 |
Why?
|
Spinal Cord Neoplasms | 3 | 2018 | 258 | 1.030 |
Why?
|
Activities of Daily Living | 24 | 2021 | 2415 | 1.020 |
Why?
|
Placebo Effect | 3 | 2021 | 514 | 0.980 |
Why?
|
Brain Injury, Chronic | 6 | 2018 | 68 | 0.970 |
Why?
|
Physical Therapy Modalities | 11 | 2021 | 533 | 0.940 |
Why?
|
Nootropic Agents | 5 | 2019 | 159 | 0.930 |
Why?
|
Osteopathic Medicine | 2 | 2021 | 13 | 0.920 |
Why?
|
Male | 251 | 2024 | 363740 | 0.900 |
Why?
|
Consciousness | 7 | 2022 | 601 | 0.890 |
Why?
|
Neuropsychological Tests | 36 | 2023 | 7119 | 0.830 |
Why?
|
Mental Disorders | 10 | 2023 | 6872 | 0.830 |
Why?
|
Adult | 174 | 2024 | 223055 | 0.820 |
Why?
|
Exercise Therapy | 6 | 2023 | 937 | 0.790 |
Why?
|
Awards and Prizes | 4 | 2019 | 364 | 0.770 |
Why?
|
Persistent Vegetative State | 5 | 2021 | 274 | 0.760 |
Why?
|
Patient Readmission | 14 | 2022 | 3284 | 0.750 |
Why?
|
Xenon | 1 | 2022 | 120 | 0.750 |
Why?
|
Middle Aged | 157 | 2024 | 223016 | 0.740 |
Why?
|
Amnesia | 4 | 2019 | 257 | 0.740 |
Why?
|
Female | 204 | 2024 | 396050 | 0.720 |
Why?
|
Craniocerebral Trauma | 8 | 2021 | 493 | 0.710 |
Why?
|
Neuronal Plasticity | 6 | 2021 | 1444 | 0.700 |
Why?
|
Quality of Life | 22 | 2023 | 13466 | 0.690 |
Why?
|
Health Status Indicators | 6 | 2020 | 967 | 0.680 |
Why?
|
Neurology | 3 | 2019 | 784 | 0.670 |
Why?
|
Vital Signs | 1 | 2021 | 147 | 0.650 |
Why?
|
Apomorphine | 2 | 2010 | 148 | 0.650 |
Why?
|
Industry | 1 | 2021 | 362 | 0.650 |
Why?
|
Length of Stay | 23 | 2022 | 6485 | 0.640 |
Why?
|
Hemiplegia | 2 | 2016 | 136 | 0.630 |
Why?
|
United States | 72 | 2024 | 72896 | 0.630 |
Why?
|
Memantine | 1 | 2020 | 110 | 0.630 |
Why?
|
Dopamine Agonists | 4 | 2010 | 346 | 0.630 |
Why?
|
Neuroprotective Agents | 7 | 2016 | 958 | 0.620 |
Why?
|
Irritable Mood | 4 | 2024 | 196 | 0.600 |
Why?
|
Military Personnel | 5 | 2023 | 1260 | 0.590 |
Why?
|
Cross-Sectional Studies | 44 | 2024 | 26276 | 0.590 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1462 | 0.580 |
Why?
|
Peer Review, Research | 1 | 2021 | 341 | 0.580 |
Why?
|
Employment | 7 | 2021 | 1106 | 0.580 |
Why?
|
Biomedical Research | 6 | 2021 | 3457 | 0.570 |
Why?
|
Consciousness Disorders | 8 | 2023 | 445 | 0.560 |
Why?
|
Depression | 16 | 2024 | 8224 | 0.560 |
Why?
|
Chordoma | 2 | 2017 | 343 | 0.560 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2077 | 0.550 |
Why?
|
Comorbidity | 14 | 2024 | 10570 | 0.530 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.530 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 12 | 2022 | 3718 | 0.530 |
Why?
|
Self Report | 14 | 2024 | 3768 | 0.530 |
Why?
|
Brain | 28 | 2024 | 27178 | 0.520 |
Why?
|
Veterans | 5 | 2022 | 2667 | 0.520 |
Why?
|
Glasgow Outcome Scale | 4 | 2021 | 101 | 0.520 |
Why?
|
Frail Elderly | 2 | 2019 | 782 | 0.510 |
Why?
|
Botulinum Toxins, Type A | 3 | 2010 | 239 | 0.510 |
Why?
|
Sleep Apnea Syndromes | 2 | 2023 | 983 | 0.510 |
Why?
|
Software Design | 1 | 2016 | 173 | 0.510 |
Why?
|
Neuromuscular Agents | 2 | 2010 | 149 | 0.500 |
Why?
|
Adolescent | 71 | 2024 | 88794 | 0.500 |
Why?
|
Chronic Disease | 10 | 2023 | 9355 | 0.500 |
Why?
|
Central Nervous System Agents | 1 | 2016 | 72 | 0.490 |
Why?
|
Aged | 92 | 2024 | 171178 | 0.490 |
Why?
|
Prospective Studies | 39 | 2024 | 54798 | 0.490 |
Why?
|
Authorship | 1 | 2018 | 288 | 0.480 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1086 | 0.480 |
Why?
|
Astrocytoma | 2 | 2018 | 772 | 0.470 |
Why?
|
Injury Severity Score | 12 | 2021 | 1049 | 0.460 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3686 | 0.460 |
Why?
|
Sciatica | 1 | 2015 | 96 | 0.460 |
Why?
|
Disabled Persons | 4 | 2022 | 1208 | 0.460 |
Why?
|
Aggression | 6 | 2024 | 747 | 0.450 |
Why?
|
Regenerative Medicine | 1 | 2018 | 303 | 0.450 |
Why?
|
Young Adult | 44 | 2024 | 59849 | 0.450 |
Why?
|
Information Systems | 1 | 2016 | 399 | 0.450 |
Why?
|
Electric Stimulation Therapy | 3 | 2021 | 634 | 0.450 |
Why?
|
Health Surveys | 5 | 2019 | 4058 | 0.440 |
Why?
|
Inservice Training | 1 | 2016 | 374 | 0.440 |
Why?
|
Central Nervous System | 2 | 2011 | 1342 | 0.430 |
Why?
|
Pediatrics | 2 | 2019 | 3602 | 0.430 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2004 | 139 | 0.430 |
Why?
|
Treatment Outcome | 40 | 2024 | 65223 | 0.420 |
Why?
|
Neuralgia | 5 | 2018 | 620 | 0.420 |
Why?
|
Wounds, Gunshot | 4 | 2014 | 586 | 0.410 |
Why?
|
Anesthesia | 1 | 2024 | 1581 | 0.410 |
Why?
|
Occupational Health | 1 | 2019 | 812 | 0.410 |
Why?
|
Amines | 2 | 2004 | 281 | 0.400 |
Why?
|
Stem Cell Transplantation | 2 | 2018 | 1601 | 0.400 |
Why?
|
Retrospective Studies | 50 | 2024 | 81505 | 0.400 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2878 | 0.400 |
Why?
|
Patient Discharge | 11 | 2022 | 3461 | 0.390 |
Why?
|
Aftercare | 1 | 2018 | 914 | 0.390 |
Why?
|
Mental Health | 6 | 2023 | 3271 | 0.390 |
Why?
|
Academies and Institutes | 2 | 2019 | 326 | 0.390 |
Why?
|
Nerve Net | 2 | 2021 | 2310 | 0.380 |
Why?
|
Environment | 7 | 2020 | 1116 | 0.370 |
Why?
|
Anxiety | 9 | 2024 | 4670 | 0.370 |
Why?
|
Sciatic Nerve | 1 | 2015 | 624 | 0.370 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1352 | 0.370 |
Why?
|
Head Injuries, Penetrating | 2 | 2001 | 28 | 0.360 |
Why?
|
Publishing | 1 | 2018 | 835 | 0.360 |
Why?
|
Cohort Studies | 24 | 2024 | 41643 | 0.360 |
Why?
|
Severity of Illness Index | 10 | 2021 | 15881 | 0.360 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1658 | 0.360 |
Why?
|
Wheelchairs | 4 | 2018 | 78 | 0.360 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3412 | 0.360 |
Why?
|
Neurosurgery | 1 | 2017 | 682 | 0.350 |
Why?
|
Prognosis | 25 | 2023 | 29915 | 0.350 |
Why?
|
Insurance, Health | 1 | 2023 | 2521 | 0.350 |
Why?
|
Longitudinal Studies | 17 | 2024 | 14745 | 0.350 |
Why?
|
Neural Stem Cells | 1 | 2018 | 897 | 0.350 |
Why?
|
Postural Balance | 5 | 2020 | 637 | 0.340 |
Why?
|
Wound Infection | 1 | 2012 | 244 | 0.340 |
Why?
|
Critical Care | 6 | 2020 | 2708 | 0.340 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2711 | 0.340 |
Why?
|
Spinal Diseases | 1 | 2015 | 561 | 0.340 |
Why?
|
Methylphenidate | 4 | 2018 | 480 | 0.340 |
Why?
|
Psychomotor Agitation | 3 | 2008 | 307 | 0.340 |
Why?
|
Double-Blind Method | 15 | 2024 | 12421 | 0.340 |
Why?
|
Trauma Centers | 5 | 2021 | 950 | 0.340 |
Why?
|
Exercise | 3 | 2018 | 5937 | 0.330 |
Why?
|
Research Report | 1 | 2013 | 367 | 0.330 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 5 | 2008 | 32 | 0.330 |
Why?
|
Robotics | 1 | 2016 | 807 | 0.330 |
Why?
|
Health Status | 6 | 2024 | 4084 | 0.320 |
Why?
|
Time Factors | 34 | 2024 | 40109 | 0.310 |
Why?
|
Benchmarking | 2 | 2019 | 1054 | 0.310 |
Why?
|
Mesenchymal Stem Cell Transplantation | 3 | 2019 | 504 | 0.310 |
Why?
|
Aging | 4 | 2024 | 8731 | 0.310 |
Why?
|
Maze Learning | 12 | 2010 | 482 | 0.310 |
Why?
|
Complementary Therapies | 3 | 2021 | 486 | 0.310 |
Why?
|
Brain Diseases | 2 | 2012 | 1551 | 0.300 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2021 | 4056 | 0.300 |
Why?
|
Walking | 6 | 2022 | 1198 | 0.300 |
Why?
|
Risk Factors | 34 | 2024 | 74853 | 0.300 |
Why?
|
Demography | 4 | 2022 | 1640 | 0.290 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2004 | 1139 | 0.290 |
Why?
|
Databases, Factual | 13 | 2021 | 8062 | 0.290 |
Why?
|
Health Promotion | 1 | 2020 | 2208 | 0.290 |
Why?
|
Aged, 80 and over | 27 | 2021 | 59506 | 0.290 |
Why?
|
Headache | 6 | 2023 | 1261 | 0.280 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1412 | 0.280 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15645 | 0.280 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2418 | 0.280 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7416 | 0.280 |
Why?
|
Stem Cells | 2 | 2018 | 3539 | 0.270 |
Why?
|
Public Health | 1 | 2020 | 2678 | 0.270 |
Why?
|
Age Factors | 19 | 2024 | 18380 | 0.260 |
Why?
|
Follow-Up Studies | 24 | 2021 | 39226 | 0.260 |
Why?
|
Patient Dropouts | 2 | 2019 | 411 | 0.260 |
Why?
|
Hypertension | 3 | 2024 | 8625 | 0.260 |
Why?
|
Neurotransmitter Agents | 2 | 2009 | 663 | 0.260 |
Why?
|
Stroke | 8 | 2023 | 9749 | 0.260 |
Why?
|
Patient Care Team | 2 | 2021 | 2513 | 0.260 |
Why?
|
Coma | 2 | 2021 | 485 | 0.260 |
Why?
|
Pilot Projects | 9 | 2024 | 8725 | 0.260 |
Why?
|
Sesquiterpenes | 2 | 2019 | 175 | 0.250 |
Why?
|
Drug Therapy | 1 | 2009 | 504 | 0.250 |
Why?
|
Institutionalization | 2 | 2017 | 108 | 0.250 |
Why?
|
Alkaloids | 2 | 2019 | 191 | 0.250 |
Why?
|
Diffusion Tensor Imaging | 6 | 2023 | 2415 | 0.240 |
Why?
|
Serotonin Receptor Agonists | 4 | 2008 | 151 | 0.240 |
Why?
|
Health Personnel | 2 | 2016 | 3386 | 0.230 |
Why?
|
Transcranial Magnetic Stimulation | 4 | 2020 | 1496 | 0.230 |
Why?
|
Biotechnology | 1 | 2006 | 284 | 0.230 |
Why?
|
Hippocampus | 8 | 2019 | 3774 | 0.230 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1475 | 0.230 |
Why?
|
Motor Activity | 13 | 2015 | 2705 | 0.230 |
Why?
|
Hand Deformities, Acquired | 1 | 2004 | 36 | 0.230 |
Why?
|
Risk Assessment | 11 | 2024 | 24278 | 0.220 |
Why?
|
Arousal | 2 | 2014 | 1175 | 0.220 |
Why?
|
Patient Transfer | 5 | 2020 | 789 | 0.220 |
Why?
|
Early Ambulation | 2 | 2016 | 49 | 0.220 |
Why?
|
Predictive Value of Tests | 12 | 2023 | 15398 | 0.220 |
Why?
|
Survivors | 6 | 2022 | 2373 | 0.220 |
Why?
|
Memory Disorders | 2 | 2015 | 1193 | 0.220 |
Why?
|
Self-Help Devices | 2 | 2021 | 62 | 0.220 |
Why?
|
Disease Management | 3 | 2023 | 2532 | 0.220 |
Why?
|
Combined Modality Therapy | 6 | 2021 | 8529 | 0.210 |
Why?
|
Cell Proliferation | 2 | 2018 | 10428 | 0.210 |
Why?
|
Dementia | 4 | 2022 | 2743 | 0.210 |
Why?
|
Patient Admission | 2 | 2020 | 1364 | 0.210 |
Why?
|
Skull Fractures | 1 | 2004 | 202 | 0.200 |
Why?
|
Upper Extremity | 3 | 2021 | 683 | 0.200 |
Why?
|
Brain Chemistry | 2 | 2017 | 952 | 0.200 |
Why?
|
Prevalence | 9 | 2024 | 15832 | 0.200 |
Why?
|
Factor Analysis, Statistical | 5 | 2016 | 999 | 0.200 |
Why?
|
Incidence | 14 | 2024 | 21501 | 0.200 |
Why?
|
Craniotomy | 4 | 2016 | 731 | 0.200 |
Why?
|
Ginkgo biloba | 1 | 2001 | 26 | 0.200 |
Why?
|
Resilience, Psychological | 2 | 2022 | 808 | 0.200 |
Why?
|
Herbal Medicine | 1 | 2001 | 37 | 0.190 |
Why?
|
Epidural Abscess | 1 | 2003 | 95 | 0.190 |
Why?
|
Central Nervous System Stimulants | 3 | 2018 | 1167 | 0.190 |
Why?
|
Gases | 1 | 2022 | 206 | 0.180 |
Why?
|
Cell Differentiation | 2 | 2018 | 11643 | 0.180 |
Why?
|
Plant Preparations | 1 | 2001 | 93 | 0.180 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4805 | 0.180 |
Why?
|
Sex Ratio | 2 | 2018 | 107 | 0.180 |
Why?
|
Headache Disorders | 1 | 2023 | 152 | 0.180 |
Why?
|
tau Proteins | 4 | 2023 | 2111 | 0.180 |
Why?
|
Schools | 8 | 2023 | 1495 | 0.180 |
Why?
|
Neural Prostheses | 1 | 2021 | 23 | 0.180 |
Why?
|
Hockey | 1 | 2021 | 96 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 16 | 2024 | 36542 | 0.180 |
Why?
|
Burns, Inhalation | 1 | 2020 | 35 | 0.180 |
Why?
|
Sex Factors | 13 | 2020 | 10607 | 0.180 |
Why?
|
Tomography, Emission-Computed | 2 | 2001 | 1006 | 0.180 |
Why?
|
Psychomotor Performance | 6 | 2014 | 1883 | 0.180 |
Why?
|
Delphi Technique | 2 | 2023 | 893 | 0.180 |
Why?
|
Paraplegia | 3 | 2018 | 159 | 0.170 |
Why?
|
Motor Cortex | 2 | 2018 | 1003 | 0.170 |
Why?
|
Animals | 37 | 2022 | 168730 | 0.170 |
Why?
|
Carbamazepine | 1 | 2021 | 224 | 0.170 |
Why?
|
Sodium Channel Blockers | 1 | 2021 | 170 | 0.170 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2019 | 20 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 19 | 2019 | 8105 | 0.170 |
Why?
|
Facial Paralysis | 1 | 2004 | 346 | 0.170 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 810 | 0.170 |
Why?
|
Education | 2 | 2021 | 531 | 0.170 |
Why?
|
Behavior Therapy | 1 | 2005 | 886 | 0.160 |
Why?
|
Phytotherapy | 1 | 2001 | 298 | 0.160 |
Why?
|
Logistic Models | 12 | 2021 | 13266 | 0.160 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2015 | 1102 | 0.160 |
Why?
|
Mind-Body Therapies | 2 | 2013 | 294 | 0.160 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3925 | 0.160 |
Why?
|
Hospitalization | 9 | 2023 | 10803 | 0.160 |
Why?
|
Temporal Bone | 1 | 2004 | 683 | 0.160 |
Why?
|
Wounds, Penetrating | 2 | 2002 | 316 | 0.160 |
Why?
|
Community Health Services | 1 | 2004 | 657 | 0.160 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2018 | 605 | 0.160 |
Why?
|
Patient Selection | 3 | 2019 | 4257 | 0.160 |
Why?
|
Occupational Diseases | 2 | 2019 | 1456 | 0.160 |
Why?
|
Age Distribution | 3 | 2019 | 2865 | 0.160 |
Why?
|
Memory | 6 | 2018 | 2191 | 0.160 |
Why?
|
After-Hours Care | 1 | 2020 | 102 | 0.160 |
Why?
|
Bone Density | 6 | 2024 | 3490 | 0.150 |
Why?
|
Pruritus | 2 | 2019 | 377 | 0.150 |
Why?
|
Carbon Monoxide | 1 | 2022 | 560 | 0.150 |
Why?
|
Trauma, Nervous System | 1 | 2018 | 35 | 0.150 |
Why?
|
Frontal Lobe | 1 | 2005 | 1409 | 0.150 |
Why?
|
Gait | 2 | 2019 | 820 | 0.150 |
Why?
|
Needs Assessment | 3 | 2018 | 1139 | 0.150 |
Why?
|
Cerebral Infarction | 2 | 2018 | 969 | 0.150 |
Why?
|
Bicycling | 1 | 2019 | 176 | 0.150 |
Why?
|
Universities | 2 | 2024 | 1004 | 0.150 |
Why?
|
Toes | 1 | 2019 | 209 | 0.150 |
Why?
|
Terminology as Topic | 3 | 2024 | 1536 | 0.150 |
Why?
|
Pamphlets | 1 | 2018 | 71 | 0.150 |
Why?
|
Adiponectin | 2 | 2014 | 1120 | 0.150 |
Why?
|
Sex Distribution | 2 | 2021 | 2268 | 0.150 |
Why?
|
Gait Disorders, Neurologic | 1 | 2020 | 245 | 0.150 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.150 |
Why?
|
Baseball | 1 | 2019 | 95 | 0.150 |
Why?
|
Violence | 3 | 2002 | 934 | 0.150 |
Why?
|
Plant Extracts | 1 | 2001 | 498 | 0.150 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.150 |
Why?
|
Caffeine | 1 | 2022 | 702 | 0.150 |
Why?
|
Osteoporosis | 4 | 2016 | 1582 | 0.150 |
Why?
|
Clinical Protocols | 2 | 2016 | 1438 | 0.140 |
Why?
|
Medicare | 5 | 2022 | 6816 | 0.140 |
Why?
|
Regression Analysis | 7 | 2021 | 6320 | 0.140 |
Why?
|
Phenols | 1 | 2001 | 522 | 0.140 |
Why?
|
Posture | 2 | 2001 | 955 | 0.140 |
Why?
|
Hyponatremia | 2 | 1997 | 278 | 0.140 |
Why?
|
Medical Futility | 1 | 2019 | 136 | 0.140 |
Why?
|
Motor Skills | 2 | 2018 | 517 | 0.140 |
Why?
|
Physical Examination | 4 | 2021 | 1263 | 0.140 |
Why?
|
Antipsychotic Agents | 5 | 2009 | 3076 | 0.140 |
Why?
|
Neurobiology | 1 | 2018 | 135 | 0.140 |
Why?
|
Sensation | 1 | 2019 | 331 | 0.140 |
Why?
|
Dopamine | 4 | 2007 | 1583 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2018 | 1336 | 0.140 |
Why?
|
Advisory Committees | 1 | 2021 | 796 | 0.140 |
Why?
|
Psychopharmacology | 1 | 2019 | 146 | 0.140 |
Why?
|
Behavior, Animal | 7 | 2013 | 1866 | 0.140 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 1881 | 0.140 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1997 | 59 | 0.140 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 241 | 0.140 |
Why?
|
Withholding Treatment | 1 | 2021 | 621 | 0.140 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2012 | 844 | 0.140 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5764 | 0.140 |
Why?
|
Journal Impact Factor | 1 | 2018 | 157 | 0.140 |
Why?
|
Subacute Care | 1 | 2019 | 183 | 0.130 |
Why?
|
Foreign-Body Migration | 1 | 1998 | 220 | 0.130 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1738 | 0.130 |
Why?
|
Exercise Tolerance | 2 | 2021 | 841 | 0.130 |
Why?
|
Osteoarthritis, Hip | 1 | 2021 | 408 | 0.130 |
Why?
|
Anger | 1 | 2019 | 402 | 0.130 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2017 | 132 | 0.130 |
Why?
|
Self Care | 2 | 2021 | 800 | 0.130 |
Why?
|
Neuromuscular Blockade | 1 | 2017 | 146 | 0.130 |
Why?
|
Patient Care Planning | 2 | 2016 | 903 | 0.130 |
Why?
|
Pain | 7 | 2024 | 5076 | 0.130 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 437 | 0.130 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1997 | 110 | 0.130 |
Why?
|
Rats | 20 | 2019 | 23707 | 0.130 |
Why?
|
Analysis of Variance | 10 | 2017 | 6204 | 0.130 |
Why?
|
Embolism, Air | 1 | 1996 | 110 | 0.130 |
Why?
|
Drinking | 1 | 1997 | 196 | 0.130 |
Why?
|
Publications | 1 | 2018 | 195 | 0.130 |
Why?
|
Drug Administration Schedule | 5 | 2017 | 4849 | 0.130 |
Why?
|
Students | 4 | 2024 | 1739 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 300 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 3 | 2024 | 704 | 0.130 |
Why?
|
Galantamine | 1 | 2015 | 33 | 0.120 |
Why?
|
Sex Characteristics | 4 | 2015 | 2643 | 0.120 |
Why?
|
Levodopa | 1 | 2016 | 221 | 0.120 |
Why?
|
Climate Change | 1 | 2022 | 509 | 0.120 |
Why?
|
Ethanol | 1 | 2001 | 1324 | 0.120 |
Why?
|
Tissue Scaffolds | 2 | 2019 | 934 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 10 | 2021 | 20680 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2805 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2018 | 707 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 2 | 2002 | 806 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4961 | 0.120 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2018 | 484 | 0.120 |
Why?
|
Models, Neurological | 2 | 2020 | 1748 | 0.120 |
Why?
|
Corpus Callosum | 1 | 2019 | 751 | 0.120 |
Why?
|
Consensus | 2 | 2023 | 3199 | 0.120 |
Why?
|
Neurologic Examination | 5 | 2006 | 913 | 0.120 |
Why?
|
Nerve Block | 1 | 2001 | 713 | 0.120 |
Why?
|
Carbolines | 1 | 2016 | 288 | 0.120 |
Why?
|
Nerve Regeneration | 1 | 2000 | 800 | 0.110 |
Why?
|
Body Temperature | 2 | 2016 | 781 | 0.110 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 249 | 0.110 |
Why?
|
Home Care Services | 1 | 2001 | 660 | 0.110 |
Why?
|
Societies, Medical | 4 | 2020 | 3950 | 0.110 |
Why?
|
Computer Security | 1 | 2016 | 261 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1238 | 0.110 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20131 | 0.110 |
Why?
|
Migraine Disorders | 3 | 2021 | 1730 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1084 | 0.110 |
Why?
|
Movement Disorders | 2 | 2010 | 460 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2017 | 763 | 0.110 |
Why?
|
Lipid Peroxidation | 3 | 2006 | 275 | 0.110 |
Why?
|
Muscle Relaxants, Central | 2 | 2004 | 94 | 0.110 |
Why?
|
Adrenergic alpha-Agonists | 2 | 2004 | 175 | 0.110 |
Why?
|
Liver Transplantation | 1 | 2005 | 2417 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2015 | 253 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2021 | 22227 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2024 | 10723 | 0.110 |
Why?
|
Subtraction Technique | 1 | 2016 | 513 | 0.100 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2013 | 40 | 0.100 |
Why?
|
Burn Units | 1 | 2013 | 143 | 0.100 |
Why?
|
Unconsciousness | 2 | 2014 | 250 | 0.100 |
Why?
|
Disease Models, Animal | 12 | 2022 | 18289 | 0.100 |
Why?
|
Bromocriptine | 2 | 2004 | 93 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3099 | 0.100 |
Why?
|
B-Cell Activating Factor | 1 | 2013 | 115 | 0.100 |
Why?
|
Recurrence | 4 | 2017 | 8506 | 0.100 |
Why?
|
Perceptual Disorders | 1 | 2015 | 199 | 0.100 |
Why?
|
Acetates | 2 | 2004 | 314 | 0.100 |
Why?
|
Muscle Weakness | 1 | 2016 | 412 | 0.100 |
Why?
|
Oxygen | 2 | 2022 | 4242 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3222 | 0.100 |
Why?
|
Retirement | 3 | 2019 | 198 | 0.100 |
Why?
|
Mental Processes | 1 | 2014 | 242 | 0.100 |
Why?
|
Intensive Care Units | 3 | 2016 | 3799 | 0.100 |
Why?
|
Osteoporotic Fractures | 2 | 2014 | 415 | 0.100 |
Why?
|
Bone Resorption | 1 | 2016 | 717 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2021 | 1415 | 0.100 |
Why?
|
Social Participation | 1 | 2014 | 187 | 0.100 |
Why?
|
Video Recording | 1 | 2017 | 969 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1393 | 0.100 |
Why?
|
Syndrome | 4 | 2021 | 3269 | 0.100 |
Why?
|
Accidents, Traffic | 4 | 2019 | 818 | 0.100 |
Why?
|
History, 21st Century | 1 | 2018 | 1573 | 0.100 |
Why?
|
Disabled Children | 1 | 2014 | 250 | 0.100 |
Why?
|
Confidentiality | 1 | 2016 | 607 | 0.100 |
Why?
|
B-Cell Maturation Antigen | 1 | 2013 | 148 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 408 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2041 | 0.100 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2015 | 279 | 0.090 |
Why?
|
Rest | 1 | 2016 | 940 | 0.090 |
Why?
|
Absorptiometry, Photon | 4 | 2024 | 1707 | 0.090 |
Why?
|
Child | 9 | 2022 | 80509 | 0.090 |
Why?
|
Feasibility Studies | 5 | 2018 | 5302 | 0.090 |
Why?
|
Skiing | 1 | 2011 | 24 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 1996 | 538 | 0.090 |
Why?
|
Abdomen | 1 | 2017 | 1133 | 0.090 |
Why?
|
Sleep | 3 | 2017 | 4819 | 0.090 |
Why?
|
Independent Living | 3 | 2022 | 584 | 0.090 |
Why?
|
Brain Ischemia | 2 | 2020 | 3001 | 0.090 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1376 | 0.090 |
Why?
|
Phototherapy | 1 | 2014 | 369 | 0.090 |
Why?
|
Executive Function | 1 | 2019 | 1391 | 0.090 |
Why?
|
Statistics, Nonparametric | 5 | 2017 | 2844 | 0.090 |
Why?
|
Spinal Cord Compression | 1 | 2013 | 234 | 0.090 |
Why?
|
Antioxidants | 1 | 2019 | 1670 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 708 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1481 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1663 | 0.090 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1248 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 931 | 0.090 |
Why?
|
Sensitivity and Specificity | 7 | 2018 | 14644 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12966 | 0.090 |
Why?
|
Registries | 3 | 2021 | 8320 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2761 | 0.090 |
Why?
|
Seizures | 3 | 2022 | 2997 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1379 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7872 | 0.090 |
Why?
|
Infusions, Subcutaneous | 1 | 2010 | 43 | 0.090 |
Why?
|
Interprofessional Relations | 2 | 2019 | 998 | 0.080 |
Why?
|
Quadriplegia | 3 | 2018 | 227 | 0.080 |
Why?
|
Haloperidol | 2 | 2008 | 394 | 0.080 |
Why?
|
Amygdala | 1 | 2018 | 1376 | 0.080 |
Why?
|
Ibuprofen | 1 | 2011 | 228 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 6014 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.080 |
Why?
|
Neck Pain | 1 | 2011 | 190 | 0.080 |
Why?
|
Risperidone | 2 | 2008 | 383 | 0.080 |
Why?
|
Subarachnoid Hemorrhage | 1 | 1997 | 1022 | 0.080 |
Why?
|
Social Environment | 2 | 2014 | 1011 | 0.080 |
Why?
|
Internship and Residency | 2 | 2019 | 5944 | 0.080 |
Why?
|
Reaction Time | 6 | 2017 | 2086 | 0.080 |
Why?
|
Pain Measurement | 5 | 2018 | 3559 | 0.080 |
Why?
|
Movement | 1 | 2016 | 1460 | 0.080 |
Why?
|
Atropine | 1 | 2009 | 242 | 0.080 |
Why?
|
Afghan Campaign 2001- | 1 | 2010 | 298 | 0.080 |
Why?
|
Research Design | 5 | 2019 | 6207 | 0.080 |
Why?
|
Maine | 2 | 2021 | 146 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1510 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1805 | 0.080 |
Why?
|
Diffuse Axonal Injury | 1 | 2009 | 49 | 0.080 |
Why?
|
Delivery of Health Care | 4 | 2021 | 5368 | 0.080 |
Why?
|
Self Efficacy | 1 | 2013 | 641 | 0.080 |
Why?
|
Testosterone | 1 | 2019 | 2495 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2839 | 0.080 |
Why?
|
Electroencephalography | 3 | 2020 | 6274 | 0.080 |
Why?
|
Deep Brain Stimulation | 1 | 2017 | 848 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1879 | 0.080 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2007 | 287 | 0.080 |
Why?
|
Blinking | 1 | 2009 | 135 | 0.080 |
Why?
|
Intention | 2 | 2021 | 346 | 0.070 |
Why?
|
Lactic Acid | 3 | 2017 | 1137 | 0.070 |
Why?
|
Verbal Learning | 2 | 2001 | 460 | 0.070 |
Why?
|
Weight Gain | 1 | 2018 | 2355 | 0.070 |
Why?
|
Estrous Cycle | 2 | 2007 | 62 | 0.070 |
Why?
|
Forearm | 1 | 2010 | 426 | 0.070 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6545 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2910 | 0.070 |
Why?
|
Hospitals | 3 | 2021 | 3887 | 0.070 |
Why?
|
Glutamic Acid | 3 | 2017 | 1180 | 0.070 |
Why?
|
Accidental Falls | 2 | 2011 | 1077 | 0.070 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2007 | 60 | 0.070 |
Why?
|
Homovanillic Acid | 1 | 2007 | 73 | 0.070 |
Why?
|
Socioeconomic Factors | 8 | 2020 | 7840 | 0.070 |
Why?
|
Medical History Taking | 1 | 2011 | 778 | 0.070 |
Why?
|
Injections | 1 | 2010 | 839 | 0.070 |
Why?
|
Anticonvulsants | 3 | 2007 | 1919 | 0.070 |
Why?
|
Psychometrics | 4 | 2018 | 3061 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2700 | 0.070 |
Why?
|
Hip Fractures | 1 | 2015 | 995 | 0.070 |
Why?
|
Hospitals, General | 1 | 2011 | 802 | 0.070 |
Why?
|
Nicotine | 2 | 2022 | 682 | 0.070 |
Why?
|
Neurons | 4 | 2019 | 9521 | 0.070 |
Why?
|
Firearms | 1 | 2014 | 630 | 0.070 |
Why?
|
Lower Extremity | 1 | 2014 | 1226 | 0.060 |
Why?
|
Odds Ratio | 4 | 2021 | 9653 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2018 | 1884 | 0.060 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 286 | 0.060 |
Why?
|
Diabetes Insipidus | 2 | 2015 | 143 | 0.060 |
Why?
|
Basal Ganglia Cerebrovascular Disease | 1 | 2005 | 7 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1191 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2513 | 0.060 |
Why?
|
Health Care Costs | 2 | 2014 | 3240 | 0.060 |
Why?
|
International Classification of Diseases | 3 | 2016 | 933 | 0.060 |
Why?
|
Attention | 2 | 2015 | 2415 | 0.060 |
Why?
|
Family | 1 | 2016 | 3208 | 0.060 |
Why?
|
Sepsis | 1 | 2019 | 2603 | 0.060 |
Why?
|
Encephalomalacia | 1 | 2005 | 18 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1308 | 0.060 |
Why?
|
Placebos | 1 | 2009 | 1659 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2009 | 772 | 0.060 |
Why?
|
Blast Injuries | 1 | 2009 | 318 | 0.060 |
Why?
|
Antidepressive Agents | 2 | 2009 | 2902 | 0.060 |
Why?
|
Cyproheptadine | 1 | 2004 | 21 | 0.060 |
Why?
|
Autoimmunity | 1 | 2013 | 1354 | 0.060 |
Why?
|
Exploratory Behavior | 2 | 2022 | 271 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1930 | 0.060 |
Why?
|
Dantrolene | 1 | 2004 | 26 | 0.060 |
Why?
|
Acute Disease | 3 | 2012 | 7237 | 0.060 |
Why?
|
Ganglia, Spinal | 2 | 2018 | 528 | 0.060 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2007 | 412 | 0.060 |
Why?
|
Hypothermia, Induced | 3 | 2005 | 754 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 17063 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 10383 | 0.060 |
Why?
|
Algorithms | 4 | 2023 | 14062 | 0.060 |
Why?
|
4-Aminopyridine | 1 | 2004 | 77 | 0.060 |
Why?
|
Neostriatum | 1 | 2005 | 231 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8927 | 0.060 |
Why?
|
Management Information Systems | 1 | 2004 | 49 | 0.060 |
Why?
|
Clinical Competence | 1 | 2000 | 4860 | 0.060 |
Why?
|
Piracetam | 1 | 2004 | 88 | 0.060 |
Why?
|
Serotonin Antagonists | 1 | 2004 | 146 | 0.060 |
Why?
|
Aging, Premature | 1 | 2024 | 44 | 0.060 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2004 | 42 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2005 | 205 | 0.060 |
Why?
|
Baclofen | 1 | 2004 | 121 | 0.060 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 408 | 0.060 |
Why?
|
Neurosciences | 1 | 2008 | 385 | 0.050 |
Why?
|
Up-Regulation | 1 | 2012 | 4133 | 0.050 |
Why?
|
Splints | 1 | 2004 | 108 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3359 | 0.050 |
Why?
|
Forecasting | 2 | 2016 | 2938 | 0.050 |
Why?
|
Florida | 1 | 2004 | 416 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2020 | 2914 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4587 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2004 | 553 | 0.050 |
Why?
|
Casts, Surgical | 1 | 2004 | 184 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2386 | 0.050 |
Why?
|
Weight-Bearing | 2 | 2016 | 529 | 0.050 |
Why?
|
Neural Conduction | 1 | 2004 | 442 | 0.050 |
Why?
|
Fluvoxamine | 1 | 2002 | 77 | 0.050 |
Why?
|
Qualitative Research | 2 | 2024 | 3135 | 0.050 |
Why?
|
Case Management | 1 | 2004 | 277 | 0.050 |
Why?
|
Germany | 2 | 2016 | 882 | 0.050 |
Why?
|
Critical Illness | 2 | 2016 | 2745 | 0.050 |
Why?
|
Multivariate Analysis | 5 | 2022 | 12056 | 0.050 |
Why?
|
Prescriptions | 1 | 2004 | 388 | 0.050 |
Why?
|
Survival Rate | 2 | 2015 | 12821 | 0.050 |
Why?
|
Ethics Committees, Research | 1 | 2023 | 196 | 0.050 |
Why?
|
Pyridines | 1 | 2014 | 2887 | 0.050 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 209 | 0.050 |
Why?
|
Paroxetine | 1 | 2002 | 181 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5445 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3251 | 0.050 |
Why?
|
Arm | 2 | 2021 | 589 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2269 | 0.050 |
Why?
|
Torticollis | 1 | 2001 | 69 | 0.050 |
Why?
|
Anisotropy | 2 | 2016 | 1284 | 0.050 |
Why?
|
Selegiline | 1 | 2001 | 31 | 0.050 |
Why?
|
Catechols | 1 | 2001 | 63 | 0.050 |
Why?
|
Sertraline | 1 | 2002 | 209 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2001 | 222 | 0.050 |
Why?
|
Glycine | 1 | 2004 | 671 | 0.050 |
Why?
|
Glioma | 1 | 2016 | 3493 | 0.050 |
Why?
|
Receptors, Presynaptic | 1 | 2000 | 15 | 0.050 |
Why?
|
Fingers | 1 | 2004 | 509 | 0.050 |
Why?
|
Benzophenones | 1 | 2001 | 58 | 0.040 |
Why?
|
Adrenergic Agonists | 1 | 2021 | 55 | 0.040 |
Why?
|
Pleasure | 1 | 2021 | 41 | 0.040 |
Why?
|
Radius | 1 | 2024 | 440 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 2010 | 0.040 |
Why?
|
California | 1 | 2024 | 1436 | 0.040 |
Why?
|
Nitrophenols | 1 | 2001 | 169 | 0.040 |
Why?
|
Smoke | 1 | 2022 | 243 | 0.040 |
Why?
|
Models, Statistical | 1 | 2014 | 5089 | 0.040 |
Why?
|
Benzothiazoles | 1 | 2001 | 246 | 0.040 |
Why?
|
Texas | 1 | 2001 | 410 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 2000 | 291 | 0.040 |
Why?
|
Swimming | 2 | 2012 | 212 | 0.040 |
Why?
|
Forensic Medicine | 1 | 2000 | 68 | 0.040 |
Why?
|
Citalopram | 1 | 2002 | 402 | 0.040 |
Why?
|
Social Adjustment | 2 | 1999 | 634 | 0.040 |
Why?
|
Vascular Headaches | 1 | 1999 | 21 | 0.040 |
Why?
|
Synaptic Transmission | 1 | 2005 | 1175 | 0.040 |
Why?
|
Middle Cerebral Artery | 1 | 2020 | 268 | 0.040 |
Why?
|
Arthritis | 1 | 2024 | 676 | 0.040 |
Why?
|
Locomotion | 2 | 2017 | 384 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2780 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2018 | 2719 | 0.040 |
Why?
|
Health Services Research | 2 | 2009 | 1811 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 93 | 0.040 |
Why?
|
Head Protective Devices | 1 | 2019 | 117 | 0.040 |
Why?
|
Random Allocation | 3 | 2010 | 2394 | 0.040 |
Why?
|
Fluoxetine | 1 | 2002 | 731 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2004 | 1135 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2017 | 15794 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2016 | 1587 | 0.040 |
Why?
|
Tibia | 1 | 2024 | 1064 | 0.040 |
Why?
|
Gait Ataxia | 1 | 2017 | 11 | 0.040 |
Why?
|
Gender Identity | 1 | 2004 | 766 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5338 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4202 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2016 | 2270 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 639 | 0.040 |
Why?
|
Research Subjects | 1 | 2019 | 248 | 0.040 |
Why?
|
Caregivers | 2 | 2024 | 2304 | 0.040 |
Why?
|
Brain Damage, Chronic | 1 | 1998 | 265 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2000 | 564 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2004 | 1595 | 0.030 |
Why?
|
Time Perception | 1 | 1998 | 87 | 0.030 |
Why?
|
Liver Diseases | 1 | 2005 | 1303 | 0.030 |
Why?
|
Ultrasonography | 1 | 2010 | 5995 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2021 | 548 | 0.030 |
Why?
|
Terminally Ill | 1 | 2019 | 240 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2010 | 1883 | 0.030 |
Why?
|
Marital Status | 1 | 2018 | 426 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2004 | 3139 | 0.030 |
Why?
|
Sensation Disorders | 1 | 2017 | 160 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 2020 | 491 | 0.030 |
Why?
|
Massachusetts | 2 | 2024 | 8875 | 0.030 |
Why?
|
Systems Analysis | 1 | 2017 | 168 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 1999 | 458 | 0.030 |
Why?
|
Homeostasis | 2 | 1998 | 3335 | 0.030 |
Why?
|
Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
Functional Laterality | 2 | 2018 | 2243 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2016 | 148 | 0.030 |
Why?
|
Orientation | 1 | 1998 | 314 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2016 | 67 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 360 | 0.030 |
Why?
|
Hematoma, Subdural | 1 | 1997 | 128 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 1997 | 655 | 0.030 |
Why?
|
Inositol | 1 | 2017 | 215 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 3677 | 0.030 |
Why?
|
Brain Hemorrhage, Traumatic | 1 | 2015 | 18 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2601 | 0.030 |
Why?
|
Debridement | 1 | 1998 | 494 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 322 | 0.030 |
Why?
|
Nitriles | 1 | 2001 | 983 | 0.030 |
Why?
|
Intracranial Hypertension | 1 | 1998 | 190 | 0.030 |
Why?
|
Minority Groups | 1 | 2003 | 1208 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6304 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 597 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2017 | 406 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 170 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3435 | 0.030 |
Why?
|
Choline | 1 | 2017 | 511 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2022 | 849 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 878 | 0.030 |
Why?
|
Life Style | 2 | 2018 | 3929 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1145 | 0.030 |
Why?
|
Hospital Costs | 1 | 2001 | 957 | 0.030 |
Why?
|
Mental Recall | 1 | 2001 | 1218 | 0.030 |
Why?
|
Wakefulness | 1 | 2022 | 1281 | 0.030 |
Why?
|
Hindlimb | 1 | 2017 | 510 | 0.030 |
Why?
|
Professional Competence | 1 | 2018 | 429 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 575 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5508 | 0.030 |
Why?
|
Long-Term Care | 1 | 2018 | 630 | 0.030 |
Why?
|
Bones of Lower Extremity | 1 | 2014 | 6 | 0.030 |
Why?
|
Anticoagulants | 1 | 2010 | 4862 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 589 | 0.030 |
Why?
|
Speech Disorders | 1 | 2015 | 178 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2015 | 315 | 0.030 |
Why?
|
Blotting, Western | 3 | 2005 | 5018 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 926 | 0.030 |
Why?
|
Computer Simulation | 2 | 2018 | 6252 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 832 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2015 | 2350 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5873 | 0.030 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 194 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1529 | 0.030 |
Why?
|
Equipment Design | 2 | 2016 | 3488 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2017 | 641 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 814 | 0.030 |
Why?
|
Infrared Rays | 1 | 2014 | 246 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2017 | 453 | 0.030 |
Why?
|
Indoles | 1 | 2001 | 1832 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2015 | 417 | 0.030 |
Why?
|
Risk | 2 | 2021 | 9600 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2019 | 687 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2000 | 1422 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 552 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 790 | 0.020 |
Why?
|
Body Mass Index | 2 | 2023 | 13041 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2014 | 441 | 0.020 |
Why?
|
Blood Pressure | 2 | 2018 | 8532 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2012 | 2896 | 0.020 |
Why?
|
Television | 1 | 2014 | 409 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1964 | 0.020 |
Why?
|
Epilepsy | 1 | 2007 | 3317 | 0.020 |
Why?
|
APACHE | 1 | 2012 | 268 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2260 | 0.020 |
Why?
|
Surgicenters | 1 | 2011 | 37 | 0.020 |
Why?
|
Water | 1 | 1997 | 1417 | 0.020 |
Why?
|
Perception | 1 | 2017 | 1204 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 2015 | 639 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 832 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2015 | 665 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13613 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8698 | 0.020 |
Why?
|
Health Policy | 2 | 2016 | 2699 | 0.020 |
Why?
|
Hearing | 1 | 2014 | 505 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2003 | 3614 | 0.020 |
Why?
|
Occupations | 1 | 2012 | 516 | 0.020 |
Why?
|
Spatial Behavior | 1 | 2010 | 88 | 0.020 |
Why?
|
Respiration | 1 | 1996 | 1652 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3894 | 0.020 |
Why?
|
Health Facility Administrators | 1 | 2009 | 32 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 30215 | 0.020 |
Why?
|
Speech | 1 | 2014 | 556 | 0.020 |
Why?
|
Hypogonadism | 1 | 2015 | 801 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22349 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81788 | 0.020 |
Why?
|
Data Collection | 1 | 2018 | 3317 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2213 | 0.020 |
Why?
|
Hand Strength | 1 | 2012 | 462 | 0.020 |
Why?
|
Progesterone | 2 | 2004 | 751 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1448 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2024 | 4303 | 0.020 |
Why?
|
Comprehension | 1 | 2014 | 636 | 0.020 |
Why?
|
Mood Disorders | 1 | 2015 | 1126 | 0.020 |
Why?
|
Hand | 1 | 2014 | 907 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3710 | 0.020 |
Why?
|
Observation | 1 | 2010 | 309 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1786 | 0.020 |
Why?
|
Femur | 1 | 2014 | 1310 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5529 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3606 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11888 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2000 | 3711 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2108 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2007 | 61 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1375 | 0.020 |
Why?
|
Blood Proteins | 1 | 2012 | 1186 | 0.020 |
Why?
|
Estrogens | 2 | 2004 | 1527 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 8039 | 0.020 |
Why?
|
Ligands | 1 | 2013 | 3273 | 0.020 |
Why?
|
Visual Perception | 1 | 2014 | 1394 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2015 | 1308 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 791 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5889 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1597 | 0.020 |
Why?
|
Medial Forebrain Bundle | 1 | 2005 | 42 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2859 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2511 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4041 | 0.020 |
Why?
|
Space Perception | 1 | 2008 | 469 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2004 | 45 | 0.020 |
Why?
|
Dextroamphetamine | 1 | 2005 | 132 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3955 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2009 | 696 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3474 | 0.010 |
Why?
|
Calcium | 1 | 1998 | 5767 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9336 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12520 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2005 | 365 | 0.010 |
Why?
|
F2-Isoprostanes | 1 | 2004 | 35 | 0.010 |
Why?
|
Electric Power Supplies | 1 | 2004 | 94 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2008 | 748 | 0.010 |
Why?
|
Patient Participation | 1 | 2013 | 1448 | 0.010 |
Why?
|
Rotation | 1 | 2005 | 513 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3563 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT1 | 1 | 2002 | 14 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11506 | 0.010 |
Why?
|
Program Development | 1 | 2009 | 1296 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 2005 | 471 | 0.010 |
Why?
|
Neurotoxins | 1 | 2004 | 238 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14445 | 0.010 |
Why?
|
Electrophysiology | 1 | 2005 | 1264 | 0.010 |
Why?
|
Anthropology, Cultural | 1 | 2003 | 103 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2013 | 2662 | 0.010 |
Why?
|
Physical Exertion | 1 | 2005 | 666 | 0.010 |
Why?
|
Bone and Bones | 1 | 2012 | 2555 | 0.010 |
Why?
|
Oxygen Radioisotopes | 1 | 2001 | 60 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 9081 | 0.010 |
Why?
|
Glioblastoma | 1 | 2016 | 3459 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2005 | 834 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2792 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2005 | 1736 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9441 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9512 | 0.010 |
Why?
|
Pennsylvania | 1 | 2001 | 616 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4779 | 0.010 |
Why?
|
Hospital Charges | 1 | 2001 | 345 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2012 | 3229 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3272 | 0.010 |
Why?
|
Vagina | 1 | 2004 | 848 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9594 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6272 | 0.010 |
Why?
|
Actins | 1 | 2005 | 2057 | 0.010 |
Why?
|
Time | 1 | 1998 | 549 | 0.010 |
Why?
|
Cues | 1 | 2001 | 877 | 0.010 |
Why?
|
Alcohol-Related Disorders | 1 | 1998 | 242 | 0.010 |
Why?
|
Attitude to Health | 1 | 2004 | 2019 | 0.010 |
Why?
|
Urban Population | 1 | 2003 | 2040 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9069 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2004 | 2235 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2005 | 2223 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5747 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36375 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 13023 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42478 | 0.010 |
Why?
|
Survival Analysis | 1 | 2003 | 10087 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23588 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4036 | 0.000 |
Why?
|
Pneumonia | 1 | 1997 | 2156 | 0.000 |
Why?
|